Company: Five Prime Therapeutics
Based: San Francisco, CA
Investors: Domain Associates, Versant Ventures, Odlander, Fredrikson & Co., Pfizer, Kleiner Perkins Caufield & Byers, Advanced Technology Ventures
Scoop: Five Prime Therapeutics is using its discovery platform to discover protein and antibody therapeutics. The company screens secreted proteins and receptors using cell-based and in vivo screening systems. It's pipeline includes FP-1030, oncology product in Phase I trials, as well as multiple preclinical and research programs in oncology, metabolic disease and immunology.